AU Patent
AU2002350719A1 — Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base
Assigned to Janssen Pharmaceutica NV · Expires 2004-06-23 · 22y expired
What this patent protects
Patent listed against Braftovi.
Drugs covered by this patent
- Braftovi (encorafenib) · Pfizer
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.